Butterfly Network (BFLY) Cash & Current Investments (2020 - 2026)
Butterfly Network (BFLY) reported Cash & Current Investments of $140.9 million for Q1 2026, down 12.44% on a YoY basis from $160.9 million in Q1 2025, and down 7.66% sequentially from $152.6 million in Q4 2025.
Butterfly Network (BFLY) Cash & Current Investments (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Cash & Current Investments data on file, last reported at $140.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 12.44% year-over-year to $140.9 million; the trailing twelve-month figure through Mar 2026 stood at $140.9 million (down 12.44% YoY), and the FY2025 full-year result was $152.6 million, up 61.74% from the prior year.
- Cash & Current Investments retreated to $140.9 million in Q1 2026, from $152.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $359.9 million in Q1 2022 to a low of $94.3 million in Q4 2024.
- A 5-year average of $173.7 million and a median of $152.6 million in 2025 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 53.23% in 2022 and soared 61.74% in 2025, its largest moves.
- Tracing BFLY's Cash & Current Investments over 5 years: stood at $197.7 million in 2022, then sank by 30.59% to $137.3 million in 2023, then slumped by 31.28% to $94.3 million in 2024, then soared by 61.74% to $152.6 million in 2025, then slipped by 7.66% to $140.9 million in 2026.
- Business Quant data shows BFLY's Cash & Current Investments at $140.9 million in Q1 2026, $152.6 million in Q4 2025, and $146.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 140.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.86 Mn |
| Dec 31, 2025 | 152.55 Mn |
| Sep 30, 2025 | 146.88 Mn |
| Jun 30, 2025 | 152.69 Mn |
| Mar 31, 2025 | 160.88 Mn |
| Dec 31, 2024 | 94.32 Mn |
| Sep 30, 2024 | 98.11 Mn |
| Jun 30, 2024 | 106.35 Mn |
| Mar 31, 2024 | 116.63 Mn |
| Dec 31, 2023 | 137.25 Mn |
| Sep 30, 2023 | 150.01 Mn |
| Jun 30, 2023 | 166.81 Mn |
| Mar 31, 2023 | 193.81 Mn |
| Dec 31, 2022 | 197.74 Mn |
| Sep 30, 2022 | 267.86 Mn |
| Jun 30, 2022 | 310.80 Mn |
| Mar 31, 2022 | 359.90 Mn |
| Dec 31, 2021 | 422.84 Mn |
| Sep 30, 2021 | 468.43 Mn |
| Jun 30, 2021 | 509.50 Mn |